1st Quarter - Report

DALRYMPLE & ASSOCIATES, LLC for SANOFI PASTEUR

Firm
Client
Income
$47,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Vaccine research and development legislation, funding, appropriations and oversight.

LobbyistCovered position, as disclosed
DONALD DALRYMPLE Principal

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; U.S. Agency for International Development (USAID); Health Resources & Services Administration (HRSA); Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); State, Dept of (DOS); White House Office; Health & Human Services, Dept of (HHS); Army, Dept of (Other); Defense, Dept of (DOD); Veterans Affairs, Dept of (VA); SENATE; Defense Threat Reduction Agency (DTRA)

Health Issues HCR

Vaccine and immunization finance, reimbursement, acquisition, regulation, standards of quality and care, liability, public health and emergency preparedness funding, legislation, appropriations and oversight.

LobbyistCovered position, as disclosed
DONALD DALRYMPLE Principal

Contacted: Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); White House Office; Defense, Dept of (DOD); Defense Threat Reduction Agency (DTRA); U.S. Agency for International Development (USAID); State, Dept of (DOS); Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES; SENATE; Army, Dept of (Other); Health Resources & Services Administration (HRSA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.